Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Apolipoproteins and Suicide: a Potential Psychiatry Biomarker

Version 1 : Received: 28 July 2022 / Approved: 9 August 2022 / Online: 9 August 2022 (05:10:32 CEST)

How to cite: Serna-Rodríguez, M.F.; Zambrano-Lucio, M.; Trejo-Luevanos, J.L.; Marino-Martínez, I.A.; Rivas-Estilla, A.M.; Ontiveros-Sánchez de la Barquera, J.A.; Perez-Maya, A.A. Apolipoproteins and Suicide: a Potential Psychiatry Biomarker. Preprints 2022, 2022080174 (doi: 10.20944/preprints202208.0174.v1). Serna-Rodríguez, M.F.; Zambrano-Lucio, M.; Trejo-Luevanos, J.L.; Marino-Martínez, I.A.; Rivas-Estilla, A.M.; Ontiveros-Sánchez de la Barquera, J.A.; Perez-Maya, A.A. Apolipoproteins and Suicide: a Potential Psychiatry Biomarker. Preprints 2022, 2022080174 (doi: 10.20944/preprints202208.0174.v1).

Abstract

Every year around 800 000 people commit suicide, this represents one death every 40 seconds. In the search for possible biological biomarkers associated with suicide and/or psychiatric disorders, serum cholesterol levels have been extensively explored. Several studies have indicated that cholesterol and associated proteins, especially apolipoproteins (Apos), may play an important role in the diagnosis, prognosis, and susceptibility of suicide. Here, we describe the current knowledge and findings in the relationship between apolipoproteins and suicide.

Keywords

apolipoprotein; suicide; biomarker; psychiatry; risk factor

Subject

BEHAVIORAL SCIENCES, Clinical Psychology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.

We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.